[1]冯克娜,张 淼,陈雅静.2型糖尿病患者血清C1q肿瘤坏死因子相关蛋白5、脂联素水平与颈动脉粥样硬化关系研究[J].陕西医学杂志,2024,(3):357-360.[doi:DOI:10.3969/j.issn.1000-7377.2024.03.015]
　FENG Kena,ZHANG Miao,CHEN Yajing.Relationship between serum CTRP5,APN levels and carotid atherosclerosis in T2DM patients[J].,2024,(3):357-360.[doi:DOI:10.3969/j.issn.1000-7377.2024.03.015]
点击复制

2型糖尿病患者血清C1q肿瘤坏死因子相关蛋白5、脂联素水平与颈动脉粥样硬化关系研究
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2024年3期
页码:
357-360
栏目:
临床研究
出版日期:
2024-03-05

文章信息/Info

Title:
Relationship between serum CTRP5,APN levels and carotid atherosclerosis in T2DM patients
作者:
冯克娜; 张 淼; 陈雅静
(保定市第二医院内分泌科,河北 保定 071000)
Author(s):
FENG Kena; ZHANG Miao; CHEN Yajing
(Department of Endocrinology,the No.2 Hospital of Baoding,Baoding 071000,China)
关键词:
2型糖尿病;  C1q肿瘤坏死因子相关蛋白5;  脂联素;  颈动脉粥样硬化;  危险因素;  关系
Keywords:
Type 2 diabetes mellitus;  Carotid atherosclerosis;  C1q tumor necrosis factor-related protein 5;  Adiponectin;  Risk factors;  Relationship
分类号:
R 587.1
DOI:
DOI:10.3969/j.issn.1000-7377.2024.03.015
文献标志码:
A
摘要:
目的:探讨2型糖尿病(T2DM)患者血清C1q肿瘤坏死因子相关蛋白5(CTRP5)、脂联素(APN)水平与颈动脉粥样硬化(CAS)的关系。方法:选择T2DM患者96例为观察组,选择体检健康者108例为对照组。采用酶联免疫吸附(ELISA)法检测血清CTRP5、APN水平。根据超声检查将T2DM患者分为CAS组和无CAS组,并比较两组一般资料及血清生化指标。分析T2DM患者发生CAS的影响因素,并进行相关性分析。结果:观察组血清CTRP5水平高于对照组,APN水平低于对照组(均P<0.05)。T2DM患者中,40例出现CAS,56例无CAS。CAS组患者年龄、空腹血糖(FPG)、糖化血红蛋白(HbA1c)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、CTRP5水平较无CAS组升高,APN水平较无CAS组下降(均P<0.05)。HbA1c、TG、LDL-C、CTRP5为CAS发生的独立危险因素,APN是CAS的独立保护因素(均P<0.05)。血清CTRP5与HbA1c、TG、LDL-C水平呈正相关,血清APN与HbA1c、TG、LDL-C水平呈负相关(均P<0.05)。结论:T2DM患者发生CAS后CTRP5水平升高,APN水平下降,CTRP5为CAS发生的独立危险因素,APN为CAS发生的独立保护因素。
Abstract:
Objective:To investigate the relationship between serum C1q tumor necrosis factor-related protein 5(CTRP5),adiponectin(APN)levels and carotid atherosclerosis(CAS)in patients with type 2 diabetes mellitus(T2DM).Methods:A total of 96 patients with T2DM were selected as observation group,and 108 healthy people were selected as control group.Serum CTRP5 and APN levels were detected by ELISA.According to the ultrasound examination,the T2DM patients were divided into CAS group and non-CAS group,and the general data and serum biochemical indexes were compared.The influencing factors of CAS in T2DM patients were analyzed,and the correlation analysis was performed.Results:Serum CTRP5 level was higher and APN level was lower in the observation group than that in the control group(all P<0.05).Among the T2DM patients,40 cases had CAS and 56 cases had no CAS.Compared with non-CAS group,the age,FPG,HbA1c,TG,HDL-C,LDL-C and CTRP5 levels were higher and the APN level was lower in CAS group(all P<0.05).HbA1c,TG,LDL-C and CTRP5 were independent risk factors for CAS,and APN was independent protective factor for CAS(all P<0.05).Serum CTRP5 was positively correlated with HbA1c,TG and LDL-C levels,and serum APN was negatively correlated with HbA1c,TG and LDL-C levels(all P<0.05).Conclusion:The level of CTRP5 increases and the level of APN decreases in T2DM patients with CAS.CTRP5 is an independent risk factor for CAS,and APN is an independent protective factor for CAS.

参考文献/References:

[1] SPEKSNIJDER E M,TEN G V,MALEKZADEH A,et al.Effect of postmenopausal hormone therapy on glucose regulation in women with type1 or type 2 diabetes:A systematic review and meta-analysis[J].Diabetes Care,2023,46(10):1866-1875.
[2] 孙家燕,张晓妍.磷酸西格列汀、二甲双胍及阿卡波糖联合应用治疗2型糖尿病伴骨质疏松疗效及对患者糖脂代谢、骨代谢水平的影响[J].陕西医学杂志,2021,50(10):1275-1278.
[3] 白小岗,李霞,贾爱华,等.2型糖尿病男性患者性激素水平与体重指数、糖脂代谢及胰岛素抵抗相关性分析[J].陕西医学杂志,2022,51(9):1086-1089.
[4] 冯艳林,李毅,马瑞,等.老年冠状动脉粥样硬化性心脏病合并糖尿病患者经皮冠状动脉介入术后应用替格瑞洛和氯吡格雷的临床疗效比较[J].中国医药,2020,15(2):178-182.
[5] 孙蔚,王慧丽,岳媛媛,等.血清炎症因子白细胞介素18、高敏C反应蛋白、肿瘤坏死因子α与2型糖尿病患者颈动脉粥样硬化的关系[J].临床内科杂志,2023,40(4):265-267.
[6] 桑丹,臧嘉斌,庄雄杰,等.新诊断2型糖尿病患者β细胞第一时相分泌功能与颈部动脉粥样硬化斑块的相关性研究[J].中国循环杂志,2022,37(2):148-153.
[7] AMALIA M,PUTERI M U,SAPUTRI F C,et al.Platelet glycoprotein-Ⅰb(GPⅠb)may serve as a bridge between type 2 diabetes mellitus(T2DM)and atherosclerosis,making it a potential target for antiplatelet agents in T2DM patients[J].Life(Basel),2023,13(7):1473.
[8] 宋炜,徐晓军,张学平.C1q坏死因子相关蛋白12、脂联素在脑动脉粥样硬化大鼠血清中的表达及其与磁共振成像技术参数相关性研究[J].陕西医学杂志,2022,51(11):1341-1345.
[9] SONG R,HU W,CHENG R,et al.Association between circulating levels of C1q/TNF-related protein-9 and type 2 diabetes mellitus:A systematic review and meta-analysis[J].J Clin Endocrinol Metab,2023,108(10):2728-2738.
[10] 刘敏,马芬.短病程2型糖尿病患者的肠道菌群分布状态与血清腺苷脱氨酶活性及脂联素水平之间的关联研究[J].临床内科杂志,2022,39(3):202-203.
[11] 蒋能美,管鑫娟,杨社珍.生长停滞特异性蛋白6和C1q/肿瘤坏死因子相关蛋白4水平与2型糖尿病患者颈动脉粥样硬化的关联[J].实用临床医药杂志,2023,27(5):123-127.
[12] 中华医学会,中华医学会杂志社,中华医学会全科医学分会,等.2 型糖尿病基层诊疗指南(实践版?2019)[J].中华全科医师杂志,2019,18(9):810-818.
[13] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国头颈部动脉粥样硬化诊治共识[J].中华神经科杂志,2017,50(8):572-578.
[14] 冯国英,曾纪斌,陈玉甜.玉液汤加减治疗2型糖尿病疗效及对患者β细胞功能、颈动脉内中膜厚度的影响[J].陕西中医,2019,40(9):1244-1246.
[15] 李向辉,卢文杰.葛黄降糖汤治疗2型糖尿病合并颈动脉硬化临床研究[J].陕西中医,2019,40(5):580-583.
[16] WANG Y,DU Y,YUAN H,et al.Human amnion-derived mesenchymal stem cells enhance the osteogenic differentiation of human adipose-derived stem cells by promoting adiponectin excretion via the APPL1-ERK1/2 signaling pathway[J].IUBMB Life,2020,72(2):296-304.
[17] 周小园,容松,田梅.姜黄素对肾缺血再灌注损伤的保护作用机制的研究进展[J].中国医药导报,2019,16(6):20-23,27.
[18] 钱子冰,张琦,曾佩芸,等.补体C1q/肿瘤坏死因子相关蛋白中CTRP3、CTRP5、CTRP9、CTRP13生物学研究进展[J].中国糖尿病杂志,2022,30(5):379-382.
[19] 褚红蔚.原发性高血压患者血清CTRP5水平与血管内皮功能相关性研究[D].石家庄:河北医科大学,2017.
[20] 彭中兴,赵云峰.C1q/肿瘤坏死因子相关蛋白家族在冠状动脉疾病中作用机制研究进展[J].南京医科大学学报:自然科学版,2021,41(10):1558-1564.
[21] 刘晶,唐威,张洁,等.血清CTRP5、脂联素与颈动脉粥样硬化的关系[J].国际内分泌代谢杂志,2022,42(1):21-26.
[22] 马英,李玉宏,杨芳,等.极速脉搏波技术评价糖化血红蛋白水平与2型糖尿病患者颈动脉脉搏波传导速度的相关性[J].中国医学影像学杂志,2020,28(6):426-430,435.
[23] 谷光宇,郭剑超,卓娜,等.初诊2型糖尿病患者中性粒细胞/淋巴细胞、血小板/淋巴细胞、平均血小板体积与早期动脉粥样硬化的关系[J].中国医师杂志,2018,20(6):861-864.
[24] 费朝霞,李红,丁明罡,等.2型糖尿病患者血清尿酸、胱抑素C、半乳糖凝集素-3、丝氨酸蛋白酶抑制剂B1与血糖及颈动脉粥样硬化的关系研究[J].现代生物医学进展,2022,22(20):3951-3955.
[25] 辛雅萍,祝艺菡,张琦,等.补体C1q/肿瘤坏死因子相关蛋白5与妊娠糖尿病的关系[J].中国医药导报,2022,19(9):75-78.

相似文献/References:

[1]李艳艳,贾 伟△.24h动态心电图在2型糖尿病合并冠心病患者心律诊断中的价值分析[J].陕西医学杂志,2019,(1):61.
[2]郭向东,马 波△.2型糖尿病患者血清胰岛素水平与骨代谢关联研究*[J].陕西医学杂志,2019,(1):77.
　GUO Xiangdong,MA Bo..Association between serum insulin level and bone metabolismin patients with type 2 diabetes mellitus[J].,2019,(3):77.
[3]刘毅龙,陈鹏宇,雷 江,等.SGLT2抑制剂在2型糖尿病合并心血管疾病治疗中的应用研究进展[J].陕西医学杂志,2019,(3):407.
[4]姚爱红.利拉鲁肽治疗2型糖尿病效果及对患者血脂、颈动脉内膜中层厚度的影响[J].陕西医学杂志,2019,(4):518.
　YAO Aihong..Effect of liraglutide on type 2 diabetes mellitus in patients with blood lipids and carotid intimamedia thickness[J].,2019,(3):518.
[5]李忆琴,吴礼凤,余晓君,等.中年2型糖尿病患者病程和HbA1c水平与认知功能相关性研究*[J].陕西医学杂志,2019,(6):722.
[6]徐 琳,贾睿博△,宋民喜,等.颗粒蛋白前体与糖尿病肾病关系探讨*[J].陕西医学杂志,2019,(8):1024.
[7]王荣锋,郁 昊,蒋新建.老年糖尿病患者血清25羟维生素D水平与骨质疏松相关性研究[J].陕西医学杂志,2019,(8):1032.
　WANG Rongfeng,YU Hao,JIANG Xinjian..The relationship between serum 25 hydroxy vitamin D and osteoporosis in elderly diabetic patients[J].,2019,(3):1032.
[8]王 荣,贾爱华,刘新艳 ,等.IGF1及其相关性因素对2型糖尿病并发骨质疏松的影响研究[J].陕西医学杂志,2019,(9):1163.
　WANG Rong,JIA Aihua,LIU Xinyan,et al.The effect of IGF1 and its related factors in type 2 diabetes complicated with osteoporosis[J].,2019,(3):1163.
[9]贾睿博,徐 琳△.2型糖尿病患者下肢血管病变相关危险因素调查研究[J].陕西医学杂志,2019,(11):1567.
[10]郭建强,赵俊宏,张分队,等.2型糖尿病视网膜病变患者血清HbA1c、CysC检测及临床意义*[J].陕西医学杂志,2020,49(5):619.
　GUO Jianqiang,ZHAO Junhong,ZHANG Fendui,et al.Changes of serum HbA1c and CysC in patients with type 2 diabetic retinopathy and their clinical significance[J].,2020,49(3):619.

备注/Memo

备注/Memo:
基金项目:河北省卫生健康委员会医学科学研究课题(20203516)
更新日期/Last Update: 2024-03-05